We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04338802
Recruitment Status : Unknown
Verified April 2020 by Huilan Zhang, Tongji Hospital.
Recruitment status was:  Not yet recruiting
First Posted : April 8, 2020
Last Update Posted : April 8, 2020
Information provided by (Responsible Party):
Huilan Zhang, Tongji Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : May 4, 2020
Estimated Study Completion Date : August 1, 2020